Semaglutide
medicationA GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
GLP-1 medications, metabolic support and the supplements people ask about alongside them.
15 compounds: 5 FDA-approved, 2 over the counter, 8 research only.
Updated September 28, 2026

compounds for weight & metabolism, each with its US status
licensed providers list at least one of them
sold over the counter, no prescription needed




A GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
A weekly GIP and GLP-1 medication approved for weight management, sleep apnea and type 2 diabetes.
An older, daily GLP-1 injection for weight management and diabetes, now available as a generic.
An investigational triple-hormone weight-loss drug from Eli Lilly. Not approved; only available in trials.
A cheap, decades-old diabetes pill that some people ask about for weight and healthy aging.
A plant compound sold as a supplement for blood sugar and weight. It is not a GLP-1 drug.
A peptide encoded by mitochondria, studied in mice for metabolism. Human data are minimal.
An FDA-approved growth-hormone-releasing peptide for belly fat in people with HIV.
A soluble fiber for regularity that also modestly lowers LDL cholesterol.
An investigational long-acting amylin analog being studied alone and with semaglutide.
An investigational glucagon and GLP-1 receptor agonist studied for obesity and liver disease.
A glucagon and GLP-1 receptor agonist approved in China but not approved in the US.
An investigational amylin-receptor agonist being studied by Eli Lilly for obesity.
A modified growth-hormone fragment promoted for fat loss without an FDA-approved use.
An investigational small-molecule weight-loss drug often grouped into RUO peptide catalogs.

Everything I want to talk through with a clinician before starting a GLP-1, plus the basics I keep reading I should not skip.